Cargando…

An Electronic Medication Module to Improve Health Literacy in Patients With Type 2 Diabetes Mellitus: Pilot Randomized Controlled Trial

BACKGROUND: In primary care, patients play a crucial role in managing care processes and handling drug treatment. A decisive factor for success is their health literacy, and several interventions have been introduced to support patients in fulfilling their responsibility. OBJECTIVE: The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Seidling, Hanna Marita, Mahler, Cornelia, Strauß, Beate, Weis, Aline, Stützle, Marion, Krisam, Johannes, Szecsenyi, Joachim, Haefeli, Walter Emil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218604/
https://www.ncbi.nlm.nih.gov/pubmed/32343246
http://dx.doi.org/10.2196/13746
_version_ 1783532833704247296
author Seidling, Hanna Marita
Mahler, Cornelia
Strauß, Beate
Weis, Aline
Stützle, Marion
Krisam, Johannes
Szecsenyi, Joachim
Haefeli, Walter Emil
author_facet Seidling, Hanna Marita
Mahler, Cornelia
Strauß, Beate
Weis, Aline
Stützle, Marion
Krisam, Johannes
Szecsenyi, Joachim
Haefeli, Walter Emil
author_sort Seidling, Hanna Marita
collection PubMed
description BACKGROUND: In primary care, patients play a crucial role in managing care processes and handling drug treatment. A decisive factor for success is their health literacy, and several interventions have been introduced to support patients in fulfilling their responsibility. OBJECTIVE: The aim of this study is to assess the influence of such an intervention (ie, a medication module) within a patient-led electronic health record on patients’ health literacy. METHODS: We conducted a randomized controlled study among community-dwelling patients with type 2 diabetes mellitus. Patients were recruited from primary care practices. After randomization, patients either had access to an internet-based medication module allowing them to store their medication information, look up drug information, and print a medication schedule (intervention group), or they received an information brochure on the importance of medication schedules (control group). After 4-8 weeks, all patients were invited to attend a structured medication review (ie, follow-up visit). Data were collected via questionnaires before the start of the intervention and during the follow-up visit. The main outcome measure was the mean difference in health literacy between baseline and follow-up assessments of patients in the control and intervention groups. RESULTS: Of 116 recruited patients, 107 (92.2%) completed the follow-up assessment and were eligible for intention-to-treat analyses. Only 73 patients, of which 29 were in the intervention group, followed the study protocol and were eligible for per-protocol analysis. No differences in overall health literacy were observed in either the intention-to-treat or in the per-protocol cohorts. Reasons for a null effect might be that the cohort was not particularly enriched with participants with low health literacy, thus precluding measurable improvement (ie, ceiling effect). Moreover, the success of implementation was considered poor because both the correct application of the study procedure (ie, randomization according to the protocol and dropout of 29 patients) and the actual interaction with the medication module was modest (ie, dropout of 9 patients). CONCLUSIONS: The conduct of this randomized controlled study was challenging, leaving it open whether inadequate implementation, too short of a duration, or insufficient efficacy of the intervention, as such, contributed to the null effect of this study. This clearly outlines the value of piloting complex interventions and the accompanying process evaluations.
format Online
Article
Text
id pubmed-7218604
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-72186042020-05-18 An Electronic Medication Module to Improve Health Literacy in Patients With Type 2 Diabetes Mellitus: Pilot Randomized Controlled Trial Seidling, Hanna Marita Mahler, Cornelia Strauß, Beate Weis, Aline Stützle, Marion Krisam, Johannes Szecsenyi, Joachim Haefeli, Walter Emil JMIR Form Res Original Paper BACKGROUND: In primary care, patients play a crucial role in managing care processes and handling drug treatment. A decisive factor for success is their health literacy, and several interventions have been introduced to support patients in fulfilling their responsibility. OBJECTIVE: The aim of this study is to assess the influence of such an intervention (ie, a medication module) within a patient-led electronic health record on patients’ health literacy. METHODS: We conducted a randomized controlled study among community-dwelling patients with type 2 diabetes mellitus. Patients were recruited from primary care practices. After randomization, patients either had access to an internet-based medication module allowing them to store their medication information, look up drug information, and print a medication schedule (intervention group), or they received an information brochure on the importance of medication schedules (control group). After 4-8 weeks, all patients were invited to attend a structured medication review (ie, follow-up visit). Data were collected via questionnaires before the start of the intervention and during the follow-up visit. The main outcome measure was the mean difference in health literacy between baseline and follow-up assessments of patients in the control and intervention groups. RESULTS: Of 116 recruited patients, 107 (92.2%) completed the follow-up assessment and were eligible for intention-to-treat analyses. Only 73 patients, of which 29 were in the intervention group, followed the study protocol and were eligible for per-protocol analysis. No differences in overall health literacy were observed in either the intention-to-treat or in the per-protocol cohorts. Reasons for a null effect might be that the cohort was not particularly enriched with participants with low health literacy, thus precluding measurable improvement (ie, ceiling effect). Moreover, the success of implementation was considered poor because both the correct application of the study procedure (ie, randomization according to the protocol and dropout of 29 patients) and the actual interaction with the medication module was modest (ie, dropout of 9 patients). CONCLUSIONS: The conduct of this randomized controlled study was challenging, leaving it open whether inadequate implementation, too short of a duration, or insufficient efficacy of the intervention, as such, contributed to the null effect of this study. This clearly outlines the value of piloting complex interventions and the accompanying process evaluations. JMIR Publications 2020-04-28 /pmc/articles/PMC7218604/ /pubmed/32343246 http://dx.doi.org/10.2196/13746 Text en ©Hanna Marita Seidling, Cornelia Mahler, Beate Strauß, Aline Weis, Marion Stützle, Johannes Krisam, INFOPAT P4/P5 Study Team, Joachim Szecsenyi, Walter Emil Haefeli. Originally published in JMIR Formative Research (http://formative.jmir.org), 28.04.2020. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on http://formative.jmir.org, as well as this copyright and license information must be included.
spellingShingle Original Paper
Seidling, Hanna Marita
Mahler, Cornelia
Strauß, Beate
Weis, Aline
Stützle, Marion
Krisam, Johannes
Szecsenyi, Joachim
Haefeli, Walter Emil
An Electronic Medication Module to Improve Health Literacy in Patients With Type 2 Diabetes Mellitus: Pilot Randomized Controlled Trial
title An Electronic Medication Module to Improve Health Literacy in Patients With Type 2 Diabetes Mellitus: Pilot Randomized Controlled Trial
title_full An Electronic Medication Module to Improve Health Literacy in Patients With Type 2 Diabetes Mellitus: Pilot Randomized Controlled Trial
title_fullStr An Electronic Medication Module to Improve Health Literacy in Patients With Type 2 Diabetes Mellitus: Pilot Randomized Controlled Trial
title_full_unstemmed An Electronic Medication Module to Improve Health Literacy in Patients With Type 2 Diabetes Mellitus: Pilot Randomized Controlled Trial
title_short An Electronic Medication Module to Improve Health Literacy in Patients With Type 2 Diabetes Mellitus: Pilot Randomized Controlled Trial
title_sort electronic medication module to improve health literacy in patients with type 2 diabetes mellitus: pilot randomized controlled trial
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218604/
https://www.ncbi.nlm.nih.gov/pubmed/32343246
http://dx.doi.org/10.2196/13746
work_keys_str_mv AT seidlinghannamarita anelectronicmedicationmoduletoimprovehealthliteracyinpatientswithtype2diabetesmellituspilotrandomizedcontrolledtrial
AT mahlercornelia anelectronicmedicationmoduletoimprovehealthliteracyinpatientswithtype2diabetesmellituspilotrandomizedcontrolledtrial
AT straußbeate anelectronicmedicationmoduletoimprovehealthliteracyinpatientswithtype2diabetesmellituspilotrandomizedcontrolledtrial
AT weisaline anelectronicmedicationmoduletoimprovehealthliteracyinpatientswithtype2diabetesmellituspilotrandomizedcontrolledtrial
AT stutzlemarion anelectronicmedicationmoduletoimprovehealthliteracyinpatientswithtype2diabetesmellituspilotrandomizedcontrolledtrial
AT krisamjohannes anelectronicmedicationmoduletoimprovehealthliteracyinpatientswithtype2diabetesmellituspilotrandomizedcontrolledtrial
AT anelectronicmedicationmoduletoimprovehealthliteracyinpatientswithtype2diabetesmellituspilotrandomizedcontrolledtrial
AT szecsenyijoachim anelectronicmedicationmoduletoimprovehealthliteracyinpatientswithtype2diabetesmellituspilotrandomizedcontrolledtrial
AT haefeliwalteremil anelectronicmedicationmoduletoimprovehealthliteracyinpatientswithtype2diabetesmellituspilotrandomizedcontrolledtrial
AT seidlinghannamarita electronicmedicationmoduletoimprovehealthliteracyinpatientswithtype2diabetesmellituspilotrandomizedcontrolledtrial
AT mahlercornelia electronicmedicationmoduletoimprovehealthliteracyinpatientswithtype2diabetesmellituspilotrandomizedcontrolledtrial
AT straußbeate electronicmedicationmoduletoimprovehealthliteracyinpatientswithtype2diabetesmellituspilotrandomizedcontrolledtrial
AT weisaline electronicmedicationmoduletoimprovehealthliteracyinpatientswithtype2diabetesmellituspilotrandomizedcontrolledtrial
AT stutzlemarion electronicmedicationmoduletoimprovehealthliteracyinpatientswithtype2diabetesmellituspilotrandomizedcontrolledtrial
AT krisamjohannes electronicmedicationmoduletoimprovehealthliteracyinpatientswithtype2diabetesmellituspilotrandomizedcontrolledtrial
AT electronicmedicationmoduletoimprovehealthliteracyinpatientswithtype2diabetesmellituspilotrandomizedcontrolledtrial
AT szecsenyijoachim electronicmedicationmoduletoimprovehealthliteracyinpatientswithtype2diabetesmellituspilotrandomizedcontrolledtrial
AT haefeliwalteremil electronicmedicationmoduletoimprovehealthliteracyinpatientswithtype2diabetesmellituspilotrandomizedcontrolledtrial